Hjem › Livmodercancer › Ohio
Livmodercancer kliniske forsøg i Ohio
6 studier for Livmodercancer søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Miami Valley Hospital South, Centerville
- SCC at UH Geauga Medical Center, Chardon
- University Hospitals Cleveland Medical Center, Cleveland
- og 12 flere
RekruttererFase 4
Alder 18 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT06952660DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Cincinnati
- Research Site, Columbus
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 3. sep. 2026 · NCT06989112Investigations of Reproductive Cancers in Women
- Summa Health, Akron
- The Ohio State University, Columbus
RekruttererObservationsstudie
Alder 45 til 100 · Kvinder · Opdateret 17. aug. 2026 · NCT06527157Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Cincinnati
- Research Site, Cleveland
- Research Site, Cleveland
- og 4 flere
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 29. jul. 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Nationwide Children's Hospital, Colombus
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
- Taylor Cancer Research Center, Maumee
RekruttererFase 2
Alder 8 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT05503797Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.